急性肾损伤早期生物学标志物的研究现状-《医学研究与战创伤救治》（原医学研究生学报）

参考文献/References:

[1]Khwaja A. KDIGO clinical practice guidelines for acute kidney injury[J].Nephron ClinPract，2012，120（4）：c179-84.
[2]张凯悦，季大玺. 当代急性肾损伤诊断标准的沿革[J].医学研究生学报，2013，26（1）:98-102.
[3]Lameire NH，Bagga A，Cruz D，et al. Acute kidney injury: an increasing global concern[J].Lancet，2013，382（9887）：170-179.
[4]Coca SG，Yusuf B，Shlipak MG，et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury：a systematic review and meta-analysis[J].Am J Kidney Dis，2009，53（6）：961-973.
[5]Singer E，Markó L，Paragas N，et al. Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications[J].Acta Physiol(Oxf)，2013，207（4）：663-672.
[6]Nickolas TL，Schmidt-Ott KM，Canetta P，et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study[J].J Am Coll Cardiol，2012，59（3）：246-255.
[7]Cruz DN，de Cal M，Garzotto F，et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population[J].Intensive Care Med，2010，36（3）：444-451.
[8]唐荣，敖翔，钟永，等. 尿L-FABP与尿NGAL联合应用在儿童心脏术后急性肾损伤早期诊断中的价值[J].中国当代儿科杂志，2017，19（7）：770-775.
[9]石艳，靳英丽，王艳晶，等. KIM-1在UUO大鼠肾脏表达的研究[J].中国实验诊断学，2010，14（10）：1545-1548.
[10]Sabbisetti VS，Waikar SS，Antoine DJ，et al. Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes[J].J Am Soc Nephrol，2014，25（10）：2177-2186.
[11]谷翠芝，李清初，曾凝，等.急性肾损伤患者NGAL、KIM-1与血肌酐的相关性[J].广东医学，2015，36（20）：3179-3181.
[12]罗亮，杨承健，陆肖娴，等. 尿液中肾损伤标志物对急性呼吸窘迫综合征并发急性肾损伤的诊断预后价值[J].医学研究生学报，2016，29（8）：827-831.
[13]Dieterle F，Sistare F，Goodsaid F，et al. Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium[J].Nat Biotechnol，2010，28（5）：455-462.
[14]Christopher D. FDA，European Medicines Agency to consider additional test results when assessing new drug safety collaborative effort by FDA and EMEA expected to yield additional safety date [EB/OL].FDA，（2008-07-12）
[2009-06-18].http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116911.htm.
[15]吴继明，刘畅，安成，等. 急性肾损伤患者尿液中KIM-1及NGAL的变化[J].现代中西医结合杂志，2010，19（12）：1431-1433.
[16]Urbschat A，Obermüller N. Biomarkers of kidney injury[J].Biomarkers，2011，16 Suppl 1：S22-30.
[17]肖威，汪杨. 白细胞介素18在诊断急性肾损伤的应用价值探讨[J].临床荟萃，2013，28（12）：1330-1332.
[18]Lin X，Yuan J，Zhao Y. Urine interleukin-18 in prediction of acute kidney injury: a systemic review and meta-analysis[J].J Nephrol，2015，28（1）：7-16.
[19]周明明，蒋正英，李蕊，等. 血清胱抑素C联合尿白介素18对脓毒症并发急性肾损伤的早期预测价值[J].中国全科医学，2016，19（8）：898-902.
[20]Arthur JM，Hill EG，Alge JL，et al. Evaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery[J].Kidney Int，2014，85（2）：431-438.
[21]Smathers RL.The human fatty acid-binding protein family：evolutionary divergences and functions[J].Hum Genomics，2011，5（3）：170-191.
[22]Susantitaphong P，Siribamrungwong M，Doi K，et al. Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis[J].Am J Kidney Dis，2013，61（3）：430-439.
[23]Xie Y，Xue W，Shao X，et al. Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomes[J].PLoS One，2014，9（11）：e112865.
[24]Xie Y，Xu W，Wang Q，et al. Urinary excretion of liver-type FABP as a new clinical marker for the progression of obstructive nephropathy[J].Biomark Med，2014，8（4）：543-556.
[25]Yamamoto T，Noiri E，Ono Y，et al. Renal L-type fatty acid--binding protein in acute ischemic injury[J].J Am SocNephrol，2007，18（11）：2894-2902.
[26]Matsui K，Kamijo-Ikemorif A，Sugaya T，et al. Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity[J].Am J Pathol，2011，178（3）：1021-1032.
[27]Fujiu K，Manabe I. Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice[J].JClin Invest，2011，121（9）：3425-3441.
[28]Ebbing J，Seibert FS，Pagonas N，et al. Dynamics of Urinary Calprotectin after Renal Ischaemia[J].PLoS One，2016，11（1）：e0146395.
[29]Heller F，Frischmann S，Grünbaum M，et al. Urinary calprotectin and the distinction between prerenal and intrinsic acute kidney injury[J].Clin J Am Soc Nephrol，2011，6（10）：2347-2355.
[30]Westhoff JH，Fichtner A，Waldherr S，et al. Urinary biomarkers for the differentiation of prerenal and intrinsic pediatric acute kidney injury[J].Pediatr Nephrol，2016，31（12）：2353-2363.
[31]Dieterle F，Perentes E，Cordier A，et al. Urinary clusterin, cystatin C， beta2-microglobulin and total protein as markers to detect drug-induced kidney injury[J].Nat Biotechnol，2010，28（5）：463-469.
[32]Bojic S，Kotur-Stevuljevic J，Kalezic N，et al. Diagnostic Value of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis-Associated Acute Kidney Injury[J].Tohoku J Exp Med，2015，237（2）：103-109.
[33]Lorenzen JM，Kielstein JT，Hafer C，et al.Circulating miR-210 predicts survival in critically ill patients with acute kidney injury[J].Clin J Am Soc Nephrol，2011，6（7）：1540-1546.
[34]Zou YF，Wen D，Zhao Q，et al.Urinary MicroRNA-30c-5p and MicroRNA-192-5p as potential biomarkers of ischemia-reperfusion-induced kidney injury[J].Exp Biol Med (Maywood)，2017，242（6）：657-667.
[35]Muramatsu Y，Tsujie M，Kohda Y，et al. Early detection of cysteine rich protein 61 (CYR61，CCN1) in urine following renal ischemic reperfusion injury[J].Kidney Int，2002，62（5）：1601-1610.
[36]Mosa O，Skitek M，Jerin A. Validity of Klotho，CYR61 and YKL-40 as ideal predictive biomarkers for acute kidney injury：review study[J].Sao Paulo Med J，2017，135（1）：57-65.
[37]du Cheyron D，Daubin C，Poggioli J，et al. Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF[J].Am J Kidney Dis，2003，42（3）：497-506.
[38]Girardi AC. Deciphering the mechanisms of the Na+/H+ exchanger-3 regulation in organ dysfunction[J].Am J Physiol Cell Physiol，2012，302（11）：C1569-87.
[39]Adiyanti SS.Acute Kidney Injury (AKI) biomarker[J].Acta Med Indones，2012，44（3）：246-255.

相似文献/References:

[1]周岩,章海涛,唐政.以急性肾损伤为首发表现的急性淋巴细胞白血病2例(附文献复习)[J].医学研究与战创伤救治(原医学研究生学报),2008,10(05):321.
　ZHOU Yan,ZHANG Hai-tao,TANG Zheng.Acute kidney injury complicated with acute lymphoblastic leukemia (two cases report and review literature)[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2008,10(02):321.
[2]施素华,孙琪,廖铭铭,等.腹膜透析治疗海战伤继发急性肾损伤患者的救护[J].医学研究与战创伤救治(原医学研究生学报),2015,17(02):182.[doi:10.3969/j.issn.1672-271X.2015.02.022]
[3]艾燕,周虹.原发性淀粉样变性患者行自体外周血干细胞移植并发急性肾损伤的护理[J].医学研究与战创伤救治(原医学研究生学报),2016,18(02):201.[doi:10.3969/j.issn.1672-271X.2016.02.031]
[4]王心综述,陈铖审校.沉默信息调节因子1对肾间质保护作用的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2018,20(02):177.[doi:10.3969/j.issn.1672-271X.2018.02.016]
[5]江城,王凡,陈世伟,等.血中性粒细胞明胶酶相关脂质运载蛋白及胱抑素C对输尿管结石梗阻致急性肾损伤的早期诊断价值[J].医学研究与战创伤救治(原医学研究生学报),2018,20(03):240.[doi:10.3969/j.issn.1672-271X.2018.03.005]
　JIANG Cheng,WANG Fan,CHEN Shi-wei,et al.Early diagnosis of NGAL and cystatin C in acute renal injury caused by obstruction of ureteral calculi[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(02):240.[doi:10.3969/j.issn.1672-271X.2018.03.005]
[6]刘海鹏,刘小微,朱峰,等.儿童肾性急性肾损伤病理分型与预后分析[J].医学研究与战创伤救治(原医学研究生学报),2022,24(1):40.[doi:10.3969/j.issn.1672-271X.2022.01.009]
　LIU Hai-peng,LIU Xiao-wei,ZHU Feng,et al.Analysis of pathological classification and prognosis of children with renal-acute kidney injury[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2022,24(02):40.[doi:10.3969/j.issn.1672-271X.2022.01.009]

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

文章信息/Info

参考文献/References:

相似文献/References:

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics